Berberine markedly decreased the levels of phosphorylated JAK2 and phosphorylated STAT3 in colorectal cancer cells and effectively interrupted the COX2/JAK/STAT signaling pathway [23,29], which was observed as a decrease in the level of metalloproteinases [54,83]. The gene discussed is PTGS2; the disease is colorectal cancer.